Accelerate Diagnostics, Inc. (AXDX) Financials

AXDX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2025 28.6 million 84.6 million
Dec. 31, 2024 28.6 million 84.6 million
Sept. 30, 2024 32.3 million 80.8 million
June 30, 2024 22.9 million 57.8 million

AXDX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2025 -5.1 million 964000
Dec. 31, 2024 -5.1 million 964000
Sept. 30, 2024 -3.1 million 1.2 million
June 30, 2024 -7.6 million 966000

AXDX Net Income

No data available :(

AXDX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2025 16.3 million - -
Dec. 31, 2024 16.3 million 46.8 million 3.2 million
Sept. 30, 2024 20.9 million 58.1 million 969000
June 30, 2024 9.7 million 41.2 million 1.3 million

AXDX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2025 23.3 million
Dec. 31, 2024 23.3 million
Sept. 30, 2024 24.9 million
June 30, 2024 23.1 million

AXDX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2025 - 3.8 million - -
Dec. 31, 2024 - 3.8 million 4.6 million -
Sept. 30, 2024 6000 3.8 million 5.6 million -
June 30, 2024 2000 3.9 million 5.4 million -

AXDX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2025 2.8 million 2.4 million
Dec. 31, 2024 2.8 million 2.4 million
Sept. 30, 2024 3.0 million 2.1 million
June 30, 2024 3.0 million 2.3 million

AXDX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

AXDX

Price: $0.03

52 week price:
0.01
2.09

Payout Ratio Range:
-2169.06%
-0.07%

Earnings Per Share: -2.15 USD

Exchange: NCM

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 335200

Ebitda: -16.0 million

Market Capitalization: 859917

Links: